Ferring Overstates Efficacy for Cancer Drug: FDA
Ferring Pharmaceuticals has been handed an FDA untitled letter for overstating the efficacy and indication of its injectable prostate cancer drug Firmagon in a recent sales aid.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.